RECENTLY, we reported that the preinjection (s.c.) of syngeneic methylcholanthrene-induced fibrosarcoma cells inhibited the growth of homologous tumour injected i.v. 1 or 2 days later. This effect, however, was not observed if the s.c. injection was delayed until one day after tumour challenge. In addition, this pretreatment frequently enhanced the cytostatic effect of peritoneal-exudate cells on tumour-cell monolayers (James et al., 1978) . These observations were somewhat unexpected, in view of the many reports then appearing, suggesting that transplanted tumours might promptly release products which could impair the host response against themselves, so permitting the tumour to escape surveillance (reviewed in James, 1977) .
In view of the effectiveness of the protection observed and the rapidity with which it was achieved, we decided this phenomenon was worth further investigation. The present report summarizes the results of studies undertaken; (a) to establish more conclusively the specificity of the effect, (b) to compare the protection conferred by tumour-cell inocula prepared in various ways, and (c) to ascertain the possible immunological mechanisms involved.
MATERIALS AND METHODS
Mice.-All the investigations were performed in inbred CBA/Ca male mice age 10-12 weeks. These mice were bred from stock supplied by the MRC Laboratory Animals Centre, Carshalton, Surrey.
T-cell-deprived mice were prepared by thymectomizing 5-week-old mice and subjecting them 1 week later to 800 rad wholebody irradiation with thorax shielding. About 7 weeks later the animals were used. The immune status of the T-cell-deprived mice was routinely assessed by challenging them i.p. with 3 x 108 sheep erythrocytes and determining 7-9 days later the levels of circulating antibodies (both sensitive and resistant to mereaptoethanol) by standard passive haemagglutination techniques. The mice were also checked at the time of sacrifice for thymic remnants. In certain instances, the mice were also subject to 400 rad whole-body X-irradiation with thorax shielding. A Westinghouse X-ray machine with the following physical conditions was used throughout for X-irradiation: 230 kV, 15 mA, with 0 5 mm Cu and 100 mm Al filters, a target-to-object distance of 75 cm and a delivery rate of 60 rad/min.
TABLEI.-Some chai-acteri-stic-s of the -syngeneic tumoui-s u8ed in the present -study Table I and elsewhere (James et al., 1978; Woodruff et al., 1978) . Cultured tumour cells Nx-ere geiierally used for pretreatment and challenge. These cells liad been maintained in culture for varying periods of time, under conditions previously described by Ghaffar et al., (1974) . The culture line was routinely examined for viral conta' ination, as previously described (James et ttl., 1978) and shown to be free of viruses and other micro-organisms. It will be observed from Fig. 1 (James et al., 1978) .
However, additional studies revealed that the effect observed is not universal, for certain tumours (at least at the doses used) were not able to elicit a protective effect in this short-term pre-treatment model. This is illustrated in Fig. 2 , where it can be seen that the s.c. injection of 106 A comparison of the protection achieved by tumour-cell suspensions processed in various ways An overall analysis of the data obtained in our original studies indicated that while a highly reproducible protection could be achieved after short-term pre-treatment with cultured tumour cells, a somewhat inconsistent effect was seen after the preinjection of tumour-cell suspensions obtained by pronase digestion of freshly excised tumour cells (James et al., 1978) . We decided, therefore, to compare directly the ability of both cultured and freshly excised tumour cells to inhibit tumour nodule formation after challenge with n- Additional experiments were undertaken to ascertain whether the superior protective effect obtained with cultured cells might be reduced by submitting these cells to a similar enzyme treatment to that used in the preparation of tumour-cell suspensions from freshly excised tumours, a procedure which undoubtedly removes certain cell-surface antigens. These studies revealed that both pronase-and trypsintreated cultured cells were as effective as non-enzyme-treated cultured tumour cells in eliciting the short-term protective effect (Fig. 4) . Further studies undertaken in parallel with the above, indicated that the pre-injection of 0 1 ml of a 10% v/v solution of FCS in RPMI medium had no effect on the growth of tumour cells injected i.v. 2 days later.
Possible mechanisms whereby short-term protection is achieved A number of experiments have been undertaken to help clarify the possible means whereby protection is conferred in this short-term pre-treatment model. Although these experiments failed to establish the precise mechanism involved, they nevertheless have enabled us to exelude some of the possible explanations originally advanced (James et al., 1978) .
In order to assess the possible role of macrophages we compared the protection achieved in normal mice and mice receiving a course of silica injections, which is known to severely impair macrophage function (e.g. Jones and Castro, 1977) . In essence this involved injecting mice i.p. with 2-5 mg of silica in 0 2 ml of physiological saline, on Days 4, 2 and 0, relative to i.v. challenge with tumour cells. Additional i.v. injections of 2-5 mg of silica were also given on days -3 and -1. As indicated in Fig. 5 , this intensive course of silica treatment failed to influence the protection due to short-term pre-treatment with homologous tumour cells. Further studies revealed that the protection was also not ablated by treatment with sodium auriothiomalate (1 mg/day on Days 5 to 0) adding further support to the contention that the observed effect was not macrophage mediated (see Fig. 6 ).
The possible involvement of T-dependent immune processes in this phenomenon was investigated in B-cell-deprived mice. In these experiments, mice which had been T-cell-depleted as described earlier were injected s.c. after a 7-8-week interval with 106 lethally irradiated (Table III) . However, protection was somewhat impaired (though not ablated) in mice which had been subjected to 400 rad whole-body irradiation before s.c. pre-treatment (Table IV) .
It should be noted that throughout these studies the pre-injection of 106 viable syngeneic tumour cells almost always produced tumours with diameters of 10 mm or more when they were killed 14 days after i.v. challenge.
DISCUSSION
The present results confirm our initial observations that the pre-injection of syngeneic tumour cells into mice shortly before i.v. challenge with the same tumour impairs the development of lung tumour nodules. They also indicate that (a) the effect is specific and more readily achieved with sotne tumours than others, (b) cultured tumour cells are more effective than freshly excised cells at evoking protection and (c) T-dependent cells, though not macrophages, play a crucial role in this phenomenon.
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In all experiments the preinjection of homologous tumour cells significantly inhibited the number of tumour nodules produced by the i.v. injection of tumour cells munogenic than the T3 tumour (see Table  I ). Furthermore, as the protection elicited by CCH1 is dose dependent (see James et al., 1987) it is possible that higher doses of T3 might have proved effective.
The reason why cultured CCH1 fibrosarcoma cells evoke a better protection than freshly excised cells is still far from clear. However, it should be noted that differences in host response to syngeneic cultured and freshly excised tumour cells have been noted by others. For example, recent reports indicate that cultured tumour cells elicit a more rapid infiltration of host cells than do their freshly excised counterparts (Moore and Moore, 1977) are more susceptible to immunological destruction in vivo (Pasternack et al., 1978) and may also generate a more significant cytotoxic response (Galili et al., 1978) . In addition, in our own laboratory we have seen differences in the growth rates of freshly excised and cultured tumours (see Fig. 3 ) and in their host immunoglobulin content (Bessos, Merriman and James, unpublished observations). 197, 210, 245, 246, 268, 279, 0, 0, 0, 10, 15, 33, 59, 144 G No +1 86, 103, 146, 158, 180, 193, 205, 206, 278 (Kerbel and Blakeslee, 1976) and virus (Snyder and Fox, 1978) may absorb foetal calf serum proteins from culture media. Such absorbed proteins may evoke a cellular or humoral response against themselves. The observation that the trypsin or pronase treatment of cultured cells fails to modify the protective effect they elicit suggests, at least indirectly, that the inferior effect of freshly excised cells is probably not due to the removal of antigens by these enzymes during cell preparation. Nevertheless, it must be borne in mind that deoxyribonuclease treatment was also used in the preparation of cells from freshly excised tumours and this could conceivably have altered the properties of the cells.
The alternative explanation, that the effects may be due to foetal-calf serum proteins absorbed during prolonged culture, is also unlikely. In the first place, the protective effect is tumour specific and in the second, the effect cannot be reproduced by injecting a relatively large dose of foetal calf serum 2 days before i.v. challenge. It is conceivable, however, that certain foetal-calf serum proteins are integrated into the tumour-cell surface, and that their presence augments the immunogenicity of tumour-specific transplanta-tion antigens, in the same way that viral antigens are believed to potentiate the immune response to weakly immunogenic tumours (Hellstrom et al., 1978; Kuzamaki et al., 1-978) .
While the above suggestions are of theoretical interest we feel that the differences are most probably due to the presence in the freshly excised tumour-cell preparations of host lymphoreticular cells, which somehow modulate the immune response to the tumour cells after transplantation into a new host. For example, in the light of previous observations from our laboratory on the CCH 1. tumour used in these studies (Szymaniec and James, 1976) it is conceivable that freshly excised tumour-cell suspension contained suppressor cells (either T cells or macrophages) which interfered with the developmeent of prompt and effective anti-tumour immunity. In this context it could be argued that the superior lung-colonizing properties of freshly excised tumour, over their cultured counterparts (see Fig. 3 ), was due to the presence of suppressor host cells in the freshly excised tumour-cell suspension. It should be noted however that others have recently shown that differences in the growth characteristics of freshly excised and cultured tumouLr cells are related to their capacity to produce inhibitors of macrophage chemotaxis (Pasternack et al., 1978) .
An additional possibility is that the larger tumours which arise after transplantation of freshly excised cells give less protection due to an "eclipse" phenomenon. Whatever the explanation for the differences in host responses to freshly excised and cultured tumour cells, these recent observations are undoubtedly of importance in relation to all studies using tumour isotransplants, and certainly warrant further investigation.
Although the mechanisms by which short-term protection is achieved still remains to be established, our observations to date indicate that T-cell-dependent immune responses are important, and that macrophages probably play an insignificant role. Furthermore, the fact that the effect can be achieved in cortisone acetatetreated mice suggests that a steroidresistant T-cell population is involved, thus excluding a role for steroid-sensitive suppressor-cell precursors (Schechter and Feldman, 1977) . Whatever the cells involved, our studies indicate that a radiation-sensitive precursor exists. The mature effector cells, however, are resistant to low doses of X-irradiation. It should be stressed that the protective effect conferred may be yet another example of concomitant immunity. Nevertheless, it is interesting to note that the protection conferred is not related to the size of the s.c. tumour at the time of sacrifice, and can be readily achieved in the absence of a tumour burden, namely after s.e. injection of lethally irradiated tumour cells (e.g. Table II and James et al., 1978) . In addition it should be noted that while the s.c. injection of tumour as late as one day before i.v. challenge inhibits the growth of lung tumour nodules, such treatment is ineffective if delayed until the time of i.v. challenge, even though there is no detectable difference in the size of the s.c. tumours when the animals are killed (see James et al., 1978) . Finally, whilst we have not performed studies to see whether the preinjection of tumour cells i.v. can inhibit the growth of ttumour cells injected s.c., such effects have been reported by others (Yuhas et al., 1975) .
Our studies to date do n-ot exclude the involvement of antibody-mediated processes. Among the untested possibilities are the rapid development of antibodies which might render the i.v. injected tumours susceptible to either complementmediate lysis or antibody-dependent cellular cytotoxicity mechanisms. In this connection it is interesting to note that others have observed the rapid appearance, within 2 days of tumour injection, of humoral factors which are capable of inducing antibody-dependent cellular cytotoxic reactions (Pollack and Nelson, 1975) . Finally, the possibility also exists that preinjection of tumour results in the rapid appearance of homocytotrophic antibody which might bind to mast cells in the lungs. The subsequent injection of tumours would elicit an immediate hypersensitivity response, which in some way might inhibit tumour growth.
In conclusion, the present results clearly establish that certain tumours rapidly evoke a specific immune response against themselves rather than switch off antitumour responses, as has been suggested by others (see James, 1977) . However, the precise means by which this is achieved and its relevance to the initial phases of tumour growth still remains to be established.
